Identifying optimal timing of physical therapy to mitigate Parkinson’s symptoms
Drs. Ramzi Salloum and Michael Okun co-authored new JAMA Neurology viewpoint article.
Drs. Ramzi Salloum and Michael Okun co-authored new JAMA Neurology viewpoint article.
Human trial of closed-loop DBS in four participants with difficult-to-treat Tourette syndrome finds treatment to be safe, beneficial.
Backed by a Parkinson’s Foundation grant, UF neurologists launched initiative to empower local Black and African American community through Parkinson’s education.
Under new grant, a research team co-led by Dr. Malú Gámez Tansey will investigate possible links between the immune system and neurodegeneration in frontotemporal dementia.
Study co-led by Dr. Michael Okun used temporally optimized patterned stimulation, or TOPS, as a therapy to personalize DBS treatment for Parkinson’s.
Dr. Coralie de Hemptinne honored with Stanley Fahn Junior Faculty Award to advance her research into new neuromodulation strategies for movement disorders.
Under new $2.2 million grant, multidisciplinary team to study mechanisms involved with systemic inflammation in rodent models of Alzheimer’s disease.
Four UF neuroscientists explained their research during the 2022 Alzheimer’s Association International Conference.
We’re highlighting women leading our neuro research efforts at the University of Florida. Next, we're highlighting Dr. Melissa Armstrong, the director of the Mangurian Clinical-Research Headquarters for Lewy Body Dementia at the Fixel Institute.
Dr. Shannon Chiu awarded five-year grant from NIA to investigate changes in LBD using diffusion-weighted MRI and task-based EEG.